Hansoh Pharmaceutical Group Co Ltd_ China BEST Conference Takeaways
China Securities·2025-01-12 05:33
本文档仅供上海信鱼私募基金管理有限公司18860455898研究使用，请勿外传 January 8, 2025 04:02 PM GMT Hansoh Pharmaceutical Group Co Ltd | Asia Pacific China BEST Conference Takeaways Hansoh has seen sales promotional activity recover substantially from the lows of late 2023, and maintains its double-digit sales growth target for F24. Management also indicated a >35% dividend payout for 2024, and said such a payout might be sustained in 2025. NRDL updates: The contract for Ameile has been extended with a ~8% price cut, while loxenatide wen ...